Science Explorer Interactive view Map
Company · Cambridge · United States

Editas Medicine (United States)

editasmedicine.comROR OpenAlex
Research works
58
▲ 113% vs 2013–17
Citations
2.1k
36.7 per fractional work
Top-10% rate
29.7%
record average 16.5%
Open access
65%
world 28%

Not ranked overall: Editas Medicine (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.69× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 1.19× its world share, 0 worksImmunology and Micro…Chemistry: 0.43× its world share, 0 worksChemistryHealth Professions: 0.62× its world share, 0 worksHealth ProfessionsMedicine: 2.53× its world share, 6 worksMedicineNursing: 1.36× its world share, 0 worksNursingArts and Humanities: 2.22× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 0.12× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.36× its world share, 0 worksEconomics, Econometr…Psychology: 0.22× its world share, 0 worksPsychologySocial Sciences: 1.10× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.7×. Every wedge is a field page.

Which keywords describe research at Editas Medicine (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Genome Engineering, RNA-Guided, Immunotherapy, Cancer Immunotherapy, CAR T Cells, Chimeric Antigen Receptor, Gene Therapy and Genetic Regulation.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Genome Engineering7▲ 204×1 topic
  2. RNA-Guided7▲ 204×1 topic
  3. Immunotherapy5▲ 14×6 topics
  4. Cancer Immunotherapy4▲ 54×2 topics
  5. CAR T Cells4▲ 170×1 topic
  6. Chimeric Antigen Receptor4▲ 170×1 topic
  7. Gene Therapy3▲ 20×4 topics
  8. Epidemiology3▲ 1.27×12 topics
  9. Cancer2▲ 2.9×9 topics
  10. Genetic Regulation2▲ 20×2 topics
  11. Pulmonary Hypertension2▲ 21×2 topics
  12. Cell-Free DNA2▲ 36×2 topics
  13. Sickle-cell Disease2▲ 68×1 topic
  14. Thalassemia2▲ 68×1 topic
  15. Biosensors2▲ 5.2×2 topics
  16. Clinical Trials2▲ 4.7×5 topics
  17. Macular Degeneration2▲ 23×3 topics
  18. DNA Damage2▲ 21×2 topics
  19. Retinal Stem Cells2▲ 63×1 topic
  20. Retinitis Pigmentosa2▲ 63×1 topic
  21. Environmental Monitoring1▲ 7.4×2 topics
  22. Genomic Instability1▲ 19×2 topics
  23. NK Cell Recognition1▲ 23×1 topic
  24. Natural Killer Cells1▲ 23×1 topic
  25. Targeted Therapy1▲ 11×5 topics
  26. Aneuploidy Screening1▲ 63×1 topic
  27. Chemotherapy1▲ 3.1×8 topics
  28. Gene Expression1▲ 3.7×8 topics
  29. Pluripotent Stem Cells1▲ 33×2 topics
  30. Prenatal Diagnosis1▲ 13×1 topic
  31. DNA nanotechnology1▲ 20×1 topic
  32. Genetic Variants1▲ 9.3×4 topics
  33. Health Effects1▲ 3.3×3 topics
  34. Homologous Recombination1▲ 30×2 topics
  35. Risk Assessment1▲ 3.5×2 topics
  36. Self-Assembly1▲ 5.3×1 topic
  37. AAV1▲ 27×1 topic
  38. E-Waste1▲ 35×1 topic
  39. Recycling1▲ 6.9×1 topic
  40. Viral Vectors1▲ 27×1 topic

Which research topics does Editas Medicine (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, CRISPR and Genetic Engineering, Hemoglobinopathies and Related Disorders and Photographic and Visual Arts.

CAR-T cell therapy resea…2CAR-T cell therapy research: 2 fractional worksCRISPR and Genetic Engin…1CRISPR and Genetic Engineering: 1 fractional worksHemoglobinopathies and Related Disorders: 1 fractional worksPhotographic and Visual Arts: 0 fractional worksBlood groups and transfusion: 0 fractional worksPARP inhibition in cancer therapy: 0 fractional worksGlutathione Transferases and Polymorphisms: 0 fractional worksVirus-based gene therapy research: 0 fractional worksAdvanced Breast Cancer Therapies: 0 fractional worksPhysical Education and Gymnastics: 0 fractional works
OncologyMolecular BiologyGeneticsMuseology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 2 works
  2. 2 CRISPR and Genetic Engineering Molecular Biology 1 works
  3. 3 Hemoglobinopathies and Related Disorders Genetics 1 works
  4. 4 Photographic and Visual Arts Museology 0 works
  5. 5 Blood groups and transfusion Hematology 0 works
  6. 6 PARP inhibition in cancer therapy Oncology 0 works
  7. 7 Glutathione Transferases and Polymorphisms Molecular Biology 0 works
  8. 8 Virus-based gene therapy research Genetics 0 works
  9. 9 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  10. 10 Physical Education and Gymnastics Education 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available65.0%not open35.0%

World: 28% of research is openly available.

with international co-authors23.4%domestic only76.6%

World: 19% is written across borders.

How has Editas Medicine (United States)'s research output changed?

Output in 2018–2022 was 113% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.